Try our Advanced Search for more refined results
Competition
-
November 07, 2025
Fed. Circ. Upholds PTAB Rulings Favoring Uber
The Federal Circuit on Friday refused to restore claims in a pair of patents used to track individuals, leaving in place Patent Trial and Appeal Board decisions that Uber showed the claims were invalid.
-
November 07, 2025
Gov't Contractor Says Nuclear Lid Co.'s Drawings Not Secrets
A defense contractor has asked a North Carolina federal judge to toss a suit accusing it of using one company's design drawings for replacement container lids to award an Army purchase order to a rival, arguing that no trade secrets were involved or misused.
-
November 07, 2025
UK Open To Fixes In Greencore's £1.2B Bakkavor Deal
The Competition and Markets Authority said Friday that it is likely to accept proposals by Greencore to sell its manufacturing plant for chilled sauces to get its £1.2 billion ($1.6 billion) deal for rival Bakkavor over the line.
-
November 06, 2025
Egg Producers Blamed Bird Flu While Fixing Prices, Suit Says
A New York grocer filed a proposed class action Thursday in Indiana federal court against the nation's largest conventional egg producers and two industry publications accusing them of a price-fixing conspiracy they falsely blamed on years-old bird flu outbreak.
-
November 06, 2025
Cal Poly Athletes Rip NIL Deal For Impact On Women's Sports
California Polytechnic State University athletes criticized the NCAA's $2.78 billion name, image and likeness settlement, telling a California federal judge during a hearing Thursday that it has harmed women's sports and caused inequitable cuts, while class counsel defended the deal, saying that it specifically preserves class members' Title IX rights.
-
November 06, 2025
CareFirst Urges Ban On J&J Character Talk At Stelara Trial
Health insurer CareFirst is asking a Virginia federal judge to bar Johnson & Johnson from promoting its "good character" to a jury that will weigh class claims of anticompetitive conduct and patent fraud to extend market protection on the blockbuster autoimmune drug Stelara.
-
November 06, 2025
PayPal Beats Antitrust Suit Over Merchant Rules Again
PayPal has for a second time beat a proposed class action accusing it of illegally boosting online retail prices with restrictive merchant agreements, but the consumers have one more chance to amend.
-
November 06, 2025
Sinclair Says Disney-YouTube Blackout An Antitrust Problem
Sinclair's CEO expressed frustration about the ongoing blackout of Disney programming on YouTube TV, saying the dispute between media giants raises potential antitrust concerns because local broadcasters whose stations are affiliated with Disney's ABC broadcast network have no say over whether their content is getting distributed to viewers.
-
November 06, 2025
Sutter Health Patients' Attys To Get Over $100M Fees, Costs
A California U.S. magistrate judge said Thursday that she is ready to grant final approval of a $228.5 million deal settling a 13-year case over claims that Sutter Health boosted costs by pushing all-or-nothing networks on insurers, which includes $75.4 million in attorney fees and over $28 million in litigation expenses.
-
November 06, 2025
Ex-COO Says Yale New Haven Hospital Owes Him Nearly $1M
Yale New Haven Hospital owes its former chief operating officer more than $994,000 under a noncompete agreement that guarantees him regular payments, according to a Connecticut federal lawsuit claiming that the hospital is improperly withholding the money because he supposedly did not give enough notice of his resignation.
-
November 06, 2025
Edwards Defends $945M Heart Valve Deal From FTC Challenge
Edwards Lifesciences urged a D.C. federal court to reject the Federal Trade Commission's bid to put its planned $945 million acquisition of JenaValve on hold, saying the deal will increase innovation and save the lives of thousands of people with a form of heart valve disease.
-
November 06, 2025
Judge Mehta 'Still Digging Out' From Google, Oath Keepers
U.S. District Judge Amit P. Mehta said Thursday he is still playing catch-up from a period during which his time was spent with virtually nothing but the Google search case and the prosecution of Oath Keepers charged with sedition and other crimes from the Jan. 6 storming of the U.S. Capitol.
-
November 06, 2025
Google-Epic Judge Raises Doubts About App Antitrust Deal
The California federal judge overseeing Epic Games' antitrust suit against Google expressed serious doubts Thursday about their recent deal to end their fight over Android app distribution, ordering an evidentiary hearing and warning he's not sure the proposed deal will correct Google's illegal conduct.
-
November 06, 2025
Deutsche Börse And Nasdaq Face EU Derivatives Cartel Probe
The European Commission revealed Thursday that it is investigating Deutsche Börse and Nasdaq over possible collusion to avoid competing for the listing, trading and clearing of financial derivatives.
-
November 05, 2025
DOJ Clears Google's $32B Deal To Buy Cybersecurity Co. Wiz
Google's plan to acquire Wiz for $32 billion and integrate the growing cloud security platform into Google Cloud has cleared the U.S. Department of Justice's antitrust review, the tech giant confirmed Wednesday.
-
November 05, 2025
Helium Financial Says Fired Employees Nabbed Trade Secrets
Two former employees of Washington-based Helium Financial Group LLC stole trade secrets and used them to start their own wealth management firm after they were fired, allowing them to create "a 'clone' of Helium's business model in startup form," Helium claimed in a lawsuit filed Wednesday in Seattle federal court
-
November 05, 2025
Mallinckrodt Faces Antitrust Suit Over Oxycodone Supply Halt
A generic-drug company has claimed in a lawsuit filed in Pennsylvania federal court that Mallinckrodt LLC and a subsidiary have cut off the supply of active ingredients necessary to make competing drugs that include oxycodone and acetaminophen.
-
November 05, 2025
Pharmacy Groups Urge 8th Circ. To Back Ark. PBM Limits
A pair of pharmacy trade groups is urging the Eighth Circuit to allow Arkansas to enforce a law barring pharmacy benefit managers from owning pharmacies, arguing the law is a rational response to "abusive" PBM practices.
-
November 05, 2025
AGs Defend Bid To Intervene In DOJ's HPE Merger Deal
More than a dozen Democratic attorneys general have assailed the Justice Department and Hewlett Packard Enterprise for fighting their bid to peek behind the controversial settlement clearing HPE's $14 billion purchase of Juniper Networks, telling a California federal judge that Congress created court oversight for deals just like this.
-
November 05, 2025
Microsoft Wants To Weigh In On Google Search Fixes, Too
Microsoft is urging a D.C. federal court to make sure that the limits imposed on Google in the U.S. Department of Justice's search monopolization case prevent the search giant from inking multiyear default agreements and that they reach new types of generative artificial intelligence products.
-
November 05, 2025
Mamdani Taps Ex-FTC Chief Lina Khan For NYC Transition
New York City Mayor-elect Zohran Mamdani on Wednesday named an all-woman transition team, including former Federal Trade Commission Chair Lina Khan, who attracted the ire of tech giants and corporations by spearheading the Biden administration's aggressive antitrust enforcement.
-
November 05, 2025
Apple, Google CEOs Can't Yet Be Deposed In Antitrust Suit
Consumers accusing Google of hatching a deal with Apple to make it the default search engine on the iPhone will not be allowed to depose Apple CEO Tim Cook and Google CEO Sundar Pichai as part of their antitrust case accusing Google of suppressing rival search engines.
-
November 05, 2025
FTC Wants 'Tainted' Drs. Testimony Barred From Merger Case
The Federal Trade Commission wants a D.C. federal judge to bar a pair of outside doctors and consultants from vouching for Edwards Lifesciences' planned JenaValve acquisition, arguing in a filing made public Tuesday that claims of minimal communication between the physicians' counsel and the companies were "at best, misleading."
-
November 05, 2025
Chancery Won't Let Pfizer Block $10B Novo Bid For Metsera
A Delaware vice chancellor Wednesday refused Pfizer Inc.'s emergency bid for a temporary restraining order to block Metsera Inc. from closing a now $10 billion competing bid by Novo Nordisk for the GLP-1 weight-loss drugmaker, saying Pfizer hasn't demonstrated Metsera's board acted in bad faith or that the company would suffer immediate irreparable harm.
-
November 05, 2025
Google Reaches Deal With Epic For Android App Changes
Google has agreed to make a number of changes to the way apps are distributed on Android devices in a deal with Epic Games, potentially resolving their yearslong antitrust battle after Google asked the U.S. Supreme Court to take up the case.
Expert Analysis
-
A Look At Trump 2.0 Antitrust Enforcement So Far
The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforcement tempered by traditional structural remedies for mergers, but other unprecedented actions, like the firing of Federal Trade Commission Democrats, will likely stoke heated discussion ahead, says Richard Dagen at Axinn.
-
Litigation Inspiration: How To Respond After A Loss
Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.
-
The Metamorphosis Of The Major Questions Doctrine
The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.
-
A Rapidly Evolving Landscape For Noncompetes In Healthcare
A wave of new state laws regulating noncompete agreements in the healthcare sector, varying in scope, approach and enforceability, are shaped by several factors unique to the industry and are likely to distort the market, say attorneys at Seyfarth.
-
Biotech Collaborations Can Ease Uncertainty Amid FDA Shift
As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.
-
Series
Playing Mah-Jongg Makes Me A Better Mediator
Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.
-
Tips For Business Users After 2 Key AI Copyright Decisions
Because two recent artificial intelligence copyright decisions from the Northern District of California — Bartz v. Anthropic and Kadrey v. Meta — came out mostly in favor of the developers using the plaintiffs' works to train large language models, business users should proceed with care, says Chris Wlach at Acxiom.
-
FTC Staff Cuts Unlikely To Curb Antitrust Enforcement Agenda
While Federal Trade Commission Chair Andrew Ferguson's recent commitment to reducing agency staff may seem at odds with the Trump administration's commitment to antitrust enforcement, a closer analysis shows that such reductions have little chance of derailing the president's efforts, say attorneys at Squire Patton.
-
Series
Law School's Missed Lessons: Navigating Client Trauma
Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.
-
Yacht Broker Case Highlights Industry Groups' Antitrust Risk
The Eleventh Circuit recently revived class claims against the International Yacht Brokers Association, signaling that commission-driven industries beyond real estate are vulnerable to antitrust challenges after the National Association of Realtors settled similar allegations last year, says Miles Santiago at the Southern University Law Center and Alex Hebert at Southern Compass.
-
Opinion
4 Former Justices Would Likely Frown On Litigation Funding
As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.
-
Takeaways From EU's Review Of Merger Control Guidelines
The European Commission’s newly launched consultation on the European Union’s merger guidelines will explore whether and how merger control should consider key policy objectives, such as innovation, investment incentives and security, say lawyers at Latham.
-
How Attys Can Use AI To Surface Narratives In E-Discovery
E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.
-
Capital One Deal Approval Lights Up Path For Bank M&A
The federal banking regulators' recent approval of Capital One's acquisition of Discover signals the agencies' willingness to approve large transactions and a more favorable environment generally for bank mergers under the Trump administration, say attorneys at Arnold & Porter.
-
New FCPA Guidance Creates 5 Compliance Imperatives
In light of new Foreign Corrupt Practices Act guidelines that mark a fundamental shift in enforcement priorities, companies should consider several specific steps to ensure compliance, from enhanced due diligence to robust whistleblower protections, says Andrew Wirmani at Reese Marketos.